✦ LIBER ✦

Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion

✍ Scribed by Mwe Mwe Chao; Udo Kontny; Ingo Brink; Gudrun Göhring; Annette Schmitt-Gräff; Manfred Rister; Brigitte Strahm

Publisher: Springer
Year: 2007
Tongue: English
Weight: 105 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0368-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of hematological an

Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion

✍ Francesca Patriarca; Alessandra Sperotto; Cristina Skert; Daniela Damiani; Simon 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 64 KB

Therapy-related myelodysplastic syndrome

✍ Toshie Ogasawara; Masako Yasuyama; Kiyotaka Kawauchi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

Successful rapid discontinuation of immu

Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome

✍ Kazushi Tamura; Takashi Kanazawa; Michiko Suzuki; Mikiko Koitabashi; Chitose Oga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Estimation of current leukaemia-free sur

Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model

✍ John P. Klein; Richard M. Szydlo; Charles Craddock; John M. Goldman 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th